Committed to Quality Pharmaceutical Supply
OMIO Pharma Limited is a Tanzanian pharmaceutical company established in 2022, specializing in the importation and distribution of safe, high-quality, and regulatory-compliant pharmaceutical products. The company exists to support healthcare providers with reliable access to essential, life-saving, and specialty medicines that meet real clinical needs.
At OMIO Pharma Limited, we understand that access to quality medicines is not just a supply-chain function, it is a critical component of patient care. Our operations are therefore built around strong regulatory compliance, disciplined supply-chain systems, and ethical business practices. We work closely with reputable international manufacturers and healthcare institutions to ensure medicines reach patients safely, consistently, and responsibly.
Quality, Regulatory & Compliance
OMIO Pharma Limited operates in accordance with applicable pharmaceutical laws and regulatory requirements in Tanzania. We prioritize partnerships with manufacturers that comply with internationally recognized quality standards, including WHO-GMP principles.
Our distribution practices are aligned with Good Distribution Practice (GDP) principles to safeguard product integrity, traceability, and patient safety throughout the supply chain. Quality and compliance are treated as operational fundamentals, not optional standards.
Market & Institutional Engagement
We work across both public and private healthcare sectors, supporting hospitals, specialized institutions, and healthcare programs with dependable pharmaceutical supply. Our market engagement approach emphasizes transparency, regulatory alignment, responsible pricing
considerations, and continuity of supply.
Leadership & Governance
OMIO Pharma Limited is led by professionals with backgrounds in pharmacy practice and pharmaceutical supply-chain management. Leadership is guided by a commitment to ethical governance, regulatory integrity, and long-term healthcare impact.
Decision-making is informed by both commercial responsibility and public-health priorities.